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Background. Problems with gait in Parkinson’s disease (PD) are a challenge in neurorehabilitation, partly because the mechanisms
causing the walking disability are unclear. Weakness and fatigue, which may significantly influence gait, are commonly reported by
patients with PD.Hence, the aim of this study was to investigate the association betweenweakness and fatigue andwalking ability in
patientswith PD.Methods.We recruited 25 patientswith idiopathic PDand 25 age-matched healthy adults.Themaximumvoluntary
contraction (MVC), twitch force, and voluntary activation levels were measured before and after a knee fatigue exercise. General
fatigue, central fatigue, and peripheral fatigue were quantified by exercise-induced changes in MVC, twitch force, and activation
level. In addition, subjective fatigue was measured using the Multidimensional Fatigue Inventory (MFI) and Fatigue Severity Scale
(FSS). Results. The patients with PD had lower activation levels, more central fatigue, and more subjective fatigue than the healthy
controls. There were no significant differences in twitch force or peripheral fatigue index between the two groups.The reduction in
walking speed was related to the loss of peripheral strength and PD itself. Conclusion. Fatigue and weakness of central origin were
related to PD, while peripheral strength was important for walking ability. The results suggest that rehabilitation programs for PD
should focus on improving both central and peripheral components of force.
1. Introduction
Gait disturbance significantly affects the quality of life in
patients with Parkinson’s disease (PD), particularly in the
later stages. Due to the failure of current drug treatment
for gait problems in patients with PD, neurorehabilitation
programs are gaining popularity. However, such problems
are also a big challenge for neurorehabilitation because the
mechanisms causing the walking disability in PD are largely
unknown. Fatigue and weakness are prominent symptoms
in most PD patients, and both can affect the life quality
and functional walking ability [1, 2]. Weakness of the lower
extremities has been reported to be a risk factor for indoor
falls in patients with PD [3]. Fatigue that occurs at the
early stage and then progresses as the disease advances
affects about half of the patients with idiopathic PD [2, 4],
and PD-related weakness and fatigue have been linked to
the severity and duration of PD, levodopa dose, activation
Hindawi
Neural Plasticity
Volume 2017, Article ID 1941980, 9 pages
https://doi.org/10.1155/2017/1941980
2 Neural Plasticity
failure, and comorbidities such as depression and anxiety
[4–6]. Chou and colleagues [7] reported that deep brain
stimulation surgery did not change levels of PD-related
fatigue. Understanding the mechanisms causing weakness
and fatigue would be beneficial in developing suitable reha-
bilitation strategies for patients with PD.
Fatigue is a complicated disorder that has several
domains, including physical fatigue, mental fatigue, reduced
activity, and reducedmotivation [8]. Recent studies have sug-
gested that PD-related fatigue is both a nonmotor and amotor
symptom [9, 10]. Fatigue in PD is commonly evaluated by
questionnaire-based scales such as the Fatigue Severity Scale
(FSS) [11] and Multidimensional Fatigue Inventory (MFI) [8,
12]. For example, Lou and colleagues found that PD patients
suffered more fatigue than healthy controls in mental and
physical domains using the MFI [12]. These questionnaire-
based fatigue scales are convenient for screening fatigue;
however they are subjective and cannot identify the cause or
mechanism of fatigue.
Themechanisms of PD-relatedweakness and fatigue have
yet to be clarified. Central nervous system- (CNS-) related
factors (central fatigue) and peripheral factors (peripheral
fatigue) may both contribute to weakness and fatigue [13]. It
has been shown that fatigue in patients with CNS disorders
such as multiple sclerosis involve both central and peripheral
components. Central fatigue may include mental fatigue and
a decrease in motivation [14, 15]. In contrast, peripheral
fatigue may result from neuromuscular transmission failure
along 𝛼 motor neurons, neuromuscular junctions, muscle
cell membranes, and factors within muscle fibers such as E-
C coupling failure [16]. Recent studies have reported that
the activation level (VA) of the maximum voluntary muscle
contraction (VA) is lower in patients with PD than in age-
matched controls [4, 17]. This suggests that PD patients are
prone to have central fatigue; however this phenomenon has
never been quantified.
In the laboratory, the total amount of fatigue can be
quantified by the fatigue index, which is the ratio of maxi-
mum voluntary contraction (MVC) force before versus after
fatigue-inducing exercise. Peripheral fatigue is commonly
measured by the decrease in a muscle twitch force elicited
by electrical stimulation of the peripheral nerve [18], while
central fatigue is commonly quantified as the decrease in VA
after fatigue-inducing exercise [13]. Quantifying the degree of
central versus peripheral fatigue in PD patients is important
for the development of suitable drug and rehabilitation
interventions. Therefore, the aims of this study were to (1)
investigate the level and mechanism of lower limb weakness
and fatigue and (2) correlate the measured components to
walking speed in patients with idiopathic PD.
2. Materials and Methods
2.1. Participants. The PD group included 25 patients (21
males, 4 females, mean age: 62.12 ± 10.23 years) with
idiopathic PD recruited from the outpatient clinics at the
Linkou Branch of Chang GungMemorial Hospital in Taiwan
(Table 1). Twenty-five healthy adults (8 males, 17 females,
Table 1: Characteristics of the study subjects.
Group PD (𝑁 = 25) HC (𝑁 = 25)
Gender (female/male) 4/21 17/8
Age (years) 62.12 ± 10.23 59.04 ± 9.13
Height (cm) 167.04 ± 8.51 159.26 ± 8.89
Weight (kg) 68.44 ± 11.58 59.83 ± 11.17
Modified Hoehn and Yahr
(HY) score,𝑁
HY = 1 6 —
HY = 1.5 5 —
HY = 2 6 —
HY = 2.5 4 —
HY = 3 4 —
mean age: 59.04 ± 9.13 years) were recruited from the
community as the healthy control (HC) group.The inclusion
criteria for the PD group were (1) PD diagnosed according to
theUnitedKingdomBrain BankCriteria, (2) withHoehn and
Yahr stages II-III, (3) stable medication usage, and (4) Mini-
Mental State Examination score ≥ 24. All PD patients were
tested during a clinical “ON” status, with themore severe side
being tested. The patients who had tremors when on med-
ication or during recording and those with other central or
peripheral neurological diseases or musculoskeletal injuries
of the lower limbs were excluded from the study. Only the
subjects with a sedentary lifestyle without regular exercise
were recruited in both groups to avoid the confounding
factor of physical activity level. Written informed consent
was obtained from all subjects before participation. This
study was approved by the Chang Gung Medical Foundation
Institutional Review Board.
2.2. Evaluation of Subjective Fatigue. Subjective fatigue was
evaluated in all subjects using the FSS, a 9-item statement
rating the severity of fatigue, and the MFI, a 20-item self-
report instrument designed to measure fatigue. Both tools
have been reported to have good validity and reliability [8],
and both were carefully explained by an examiner who was
blind to the purpose of this study.
2.3. Experimental Design. After a 30-minute rest, the force
of MVC, VA level, twitch force, and fatigue indexes were
evaluated. The subjects were seated on a custom-made knee
extension force measurement system, which included a force
transducer (AWU, Genisco Technology, CA, USA) coupled
to a transducer amplifier (Gould Inc., Valley View, OH,
USA), to measure the knee isometric extension force at 90
degrees of flexion [14]. Responses were sampled at 1000Hz
and recorded on a computer using a Power 1401 laboratory
interface (Cambridge Electronic Design, Cambridge, UK) for
offline analysis.
2.4. Maximum Voluntary Contraction (MVC). To record the
MVC of the quadricepsmuscle, each subject performed three
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MVCs to warm up, followed by five MVCs which were
recorded. The force trace was displayed on an oscilloscope
(MetraByte AS 1600, Keithley Instruments, Inc., Cleveland,
OH, USA) for real-time feedback. When performing MVC,
the subjects were instructed to fully contract the quadriceps
muscle for 5 seconds. Both verbal encouragement and visual
feedback were given during the contraction. A rest period of
10 seconds was given between consecutive contractions. The
amplitude of the MVC force was calculated from the force-
time curve. To avoid possible changes in force contraction
velocity before and after the fatigue-inducing exercise, the
amplitude ofMVC forcewas calculated by averaging the force
level from the force peak until 0.5 s after the peak in each
MVC.
2.5. Voluntary Activation Level (VA) Test and Twitch Forces.
VA was measured using the interpolated twitch test [14,
19]. During the test, the quadriceps muscle was stimulated
(Digitimer DS7A, Digitimer Ltd., Welwyn Court, UK) with
surface electrodes.The pulse width of stimulation was 200𝜇s,
and the stimulation intensity was supramaximal, that is, 120%
of the intensity eliciting the maximum resting twitch. The
supramaximal stimulus was delivered when the quadriceps
was at rest and during MVC to elicit the resting twitch
and the interpolated twitch (𝑇2), respectively. The resting
twitches were measured before and after MVC to obtain
unpotentiated and potentiated resting twitches, respectively.
Only the potentiated resting twitches were used (𝑇1). The
twitch forces were measured as the peak amplitude of the
twitches, and VA was calculated using the following formula:
VA = (1 − 𝑇2𝑇1) × 100%. (1)
The subjects then underwent the fatigue task, in which
they were asked to repeat 5-second isometric MVCs of the
quadriceps muscle, with 10-second rest periods in between,
for 15 minutes. The subjects were encouraged verbally and
visual feedback was provided to increase motivation during
MVC.TheMVC,VA, and twitch force were determined again
after the fatigue task. Representative data for MVC, twitch
force, and interpolated twitch force are shown in Figure 1(c).
2.6. Fatigue Indexes. The general fatigue index (GFI) was
calculated as the ratio of postfatigueMVC to prefatigueMVC,
and the central fatigue index (CFI) was calculated as the ratio
of postfatigue VA to prefatigue VA. Central fatigue refers
to a progressive decline in the ability to activate muscles
voluntarily, and it has been attributed to impairment at sites of
suprasegmental structures [13, 20]. By calculating the change
in VA caused by exercise, exercise-induced central fatigue
can be quantified. The peripheral fatigue index (PFI) was
calculated as the ratio of the postfatigue twitch force to
the prefatigue twitch force [14, 15]. The GFI, CFI, and PFI
had values between 0 and 1, with a higher value indicating
less general fatigue, central fatigue, and peripheral fatigue,
respectively.
2.7. Walking Test. Functional ambulation ability was evalu-
ated using a 6.5 m walking test. The subjects were asked to
walk 6.5m without assistance. To eliminate the influence of
acceleration and deceleration, the average walking speed was
measured over the middle 4.5m.
2.8. Data Analysis. One-way ANOVA was used to analyze
between-group differences in MVC, VA, twitch force, GFI,
CFI, PFI, MFI, FSS, and walking speed (version 9.2, SAS
Institute, Cary, NC, USA). Spearman correlation was used
to analyze the correlations among levodopa equivalent dose
(LED), UPDRS part III (motor part), and different com-
ponents of fatigue. Stepwise regression analysis was used
to identify the factors contributing to walking speed. The
significance level was set at 𝑝 < 0.05.
3. Results
All demographic and clinical data are shown in Table 1.There
was no significant difference in age between the PD (62.12 ±
10.23 years) and HC (59.04 ± 9.13 years) groups (𝑝 = 0.49).
The average LED of the patients was 258.92 ± 104.30 (range:
100–500) mg/day.
Figure 1 shows the representative force-time curves of
MVC, twitch force, and interpolated twitch for onePDpatient
((a)–(d)) and one healthy subject ((e)–(h)) before (pre) and
after (post) fatigue tests. Between-group comparisons are
shown in Figure 2. In the prefatigue state, VA was lower
in the PD group (64.35 ± 17.37%) than in the HC group
(74.65 ± 10.71%) (𝐹(1, 48) = 6.36, 𝑝 = 0.02; Figure 2(a)),
suggesting that weakness originated from central fatigue in
the PD group. There were no significant differences in MVC
(𝐹(1, 48) = 0.07, 𝑝 = 0.79) or twitch force (𝐹(1, 48) =
2.64, 𝑝 = 0.11) (Figures 2(b) and 2(c)) between the two
groups. The PD group had more subjective fatigue (MFI =
50.08 ± 14.80) than the control group (MFI = 38.52 ±
10.22) (𝐹(1, 48) = 10.33, 𝑝 < 0.01, Figure 2(d)), while
no significant difference was found in FSS between the two
groups (PD = 37 ± 13.28, control = 31.08 ± 12.67, 𝐹(1, 48) =
2.6, 𝑝 = 0.11, Figure 2(e)). The PD patients had a slower
walking speed (93.99 ± 34.6 cm/sec) than the HC group
(122.17 ± 34.27 cm/sec) (𝐹(1, 47) = 10.93, 𝑝 < 0.01,
Figure 2(f)). With regard to the fatigue indexes, fatigue-
inducing exercise was associated with a significantly lower
CFI in the PD group (79.48 ± 12.67) than in the HC group
(88.53 ± 11.68) (𝐹(1, 48) = 6.9, 𝑝 = 0.01), suggesting that
the PD patients experienced fatigue of central origin more
easily than the healthy subjects (Figure 2(g)). No between-
group differencewas observed in PFI (PD: PFI = 81.13±15.71,
HC PFI = 84.15 ± 13.37, 𝐹(1, 48) = 0.54, and 𝑝 = 0.47),
suggesting that both groups had similar levels of peripheral
fatigue (Figure 2(h)). GFI was marginally lower in the PD
group (74.22 ± 18.52) than in the HC group (84.37 ± 17.31%)
(𝐹(1, 48) = 4, 𝑝 = 0.05, Figure 2(i)).
We further performed correlation analysis between mea-
sures (Table 2). Pearson correlation coefficients showed that
MVC correlated with both VA (𝑟 = 0.56, 𝑝 < 0.001) and
resting twitch (𝑟 = 0.74, 𝑝 < 0.001) in the PD group, whereas
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Figure 1: Representative force-time curves ofMVC, twitch force, and interpolated twitch for one PD patient ((a)–(d)) and one healthy subject
((e)–(h)) before (pre) and after (post) fatigue. The 𝑦-axis shows the percentage of the peak MVC, with the prefatigue maximum set to 100%.
𝑇1: potentiated twitch was also used to represent twitch force.
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Figure 2: Differences between the PD and HC groups in (a) VA, (b) MVC, (c) twitch force, (d) MFI, (e) FSS, (f) walking speed test, exercise-
induced (g) central fatigue, (h) peripheral fatigue, and (i) general fatigue indexes in the PD and HC groups. ∗𝑝 < 0.05.
it correlated onlywith twitch force (𝑟 = 0.71,𝑝 < 0.001) in the
HC group. No significant correlations were found between
MFI and objective fatigue parameters includingGFI (PD:𝑝 =
0.27, HC: 𝑝 = 0.92), CFI (PD: 𝑝 = 0.25, HC: 𝑝 = 0.42), or PFI
(PD: 𝑝 = 0.52, HC: 𝑝 = 0.76). Stepwise regression analysis
revealed that walking speed could be affected by having PD
itself and by twitch force (𝑅-square = 0.23, 𝑝 < 0.01).
The spearman correlation analysis showed that LED and
VAcorrelatedwith theUPDRS III score (𝑟 = −0.63,𝑝 = 0.022
and 𝑟 = −0.65, 𝑝 = 0.025, resp.), but not with other parts.
Moreover, we did not find any correlations between LED and
different types of fatigue (GFI: 𝑟 = 0.12, 𝑝 = 0.57; CFI: 𝑟 =
0.25, 𝑝 = 0.22; and PFI: 𝑟 = 0.20, 𝑝 = 0.34) and/or between
UPRDS UPDRS III and different types of fatigue (GFI: 𝑟 =
0.10, 𝑝 = 0.75; CFI: 𝑟 = −0.41, 𝑝 = 0.16; and PFI: 𝑟 = 0.03,
𝑝 = 0.92).
4. Discussion
The current study revealed that PD patients had lower VA,
lower CFI, and more subjective fatigue than the HCs. The
MVC of the PD group correlated with both VA and twitch
force, whereas the MVC of the control group correlated only
with the twitch force. The slower walking speed in the PD
patients could be explained by both having the disease of PD
and loss of twitch forces.
The finding of a lower VA in the patients with PD is
consistent with previous studies [4, 17]. VA reflects the ability
of the CNS to drive the muscular system without being
confounded by peripheral muscle strength [19]. A lower
VA suggests that PD patients have subclinical weakness of
central origin. The lack of a significant difference in twitch
force between the PD and HC groups further confirms that
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Table 2: Correlation analysis between variables in the two groups.
Correlation
PD HC
MFI MVC Speed MFI MVC Speed
𝑟 𝑝 𝑟 𝑝 𝑟 𝑝 𝑟 𝑝 𝑟 𝑝 𝑟 𝑝
CFI −0.24 0.25 0.17 0.42
GFI −0.23 0.27 −0.02 0.92
PFI −0.13 0.52 −0.06 0.76
VA 0.56 <0.01∗ −0.07 0.73 0.38 0.06 0 0.99
TW 0.74 <0.01∗ 0.28 0.19 0.71 <0.01∗ 0.18 0.40
MVC 0.16 0.45 −0.14 0.51
PD, Parkinson’s disease; HC, healthy control; MFI, Multidimensional Fatigue Inventory; CFI, central fatigue index; PFI, peripheral fatigue index; GFI, general
fatigue index; VA, activation level; TW, twitch force; MVC, maximum voluntary contraction.
*Significant correlation, 𝑝 < .05.
a peripheral mechanism may not be involved. In terms of
fatigue, the PD patients had a lower CFI than the HCs, sug-
gesting that the PD patients hadmore fatigue of central origin
after exercise. Quantification of exercise-induced fatigue has
seldom been studied in PD. Although a lower activation level
and higher general fatigue have been reported [4, 17], central
and peripheral exercise-induced fatigue have never been
investigated separately in patients with PD. To the best of our
knowledge, this is the first study to identify exercise-induced
central and peripheral fatigue in PD patients using a well-
established laboratory technique that has been used in other
neurological diseases such as multiple sclerosis [14]. Stevens-
Lapsley et al. reported that general fatigue in the quadriceps
muscle was only greater in PD patients with a low motor
score but not in those with a high motor score compared to
controls [4].This is consistent with our results which revealed
only amarginally lowerGFI in the PDpatients. Together with
the finding of no difference in PFI between the PD and HC
groups, the current study confirms that fatigue in PD is of
central origin and that only the CFI is sensitive enough to
detect such fatigue.
In this study, the PD group had more exercise-induced
central fatigue and reported a higher MFI compared to the
HC group. However, no significant correlation was identified
between the MFI and CFI. The scale of the MFI, a self-
reported psychometric measurement instrument, is not lin-
ear [8], and this nonlinearity is probably the cause of the poor
correlation with the CFI.
The MVC in the PD group was significantly correlated
with both the forces of central (VA) and peripheral (resting
twitch) origin, whereas the MVC in the HC group was only
correlated with the force of peripheral origin. In addition,
there was no difference in the twitch force between the two
groups. It is generally accepted that age-related weakness is
a result of peripheral muscle weakness rather than reduced
neural drive. A study on the force of the quadriceps muscle
reported an approximately 50% lower twitch force but no
change in either mean motor unit firing rates or activation
level in older compared to younger subjects [21].The possible
factors contributing to peripheral weakness include a reduc-
tion in dietary protein, humoral effects of gonadal steroids,
increases in catabolic stimuli, and decreased levels of physical
activity [22].The correlation betweenMCV andVA in the PD
patients and the similar twitch force between the PD and HC
groups suggest that, in addition to peripheral weakness seen
in the elderly, PD patients suffer from weakness of central
origin.
No significant difference inMVC orGFI (calculated from
the change in MVC) was found between the PD and HC
groups, suggesting that MVC alone is not sensitive enough
to identify PD-related weakness. MVC measures both the
central and peripheral components of fatigue [19, 23], and it
is possible that a significant change in the central component,
for example, lower VA, in the patients with PD contributed
much less than the peripheral component resulting in similar
changes in the PD and HC groups to MVC. On the other
hand, the lower VA could be compensated by the increase
in variability of firing rate of single motor units in PD [24].
According to the force-frequency relationship, theMVC force
could be influenced by motor unit firing characteristics even
with all the motor units fully recruited by the CNS [25].
The underlying mechanisms of PD-related activation
failure and central fatigue are complicated. Central fatigue
represents a failure of physical and mental tasks that require
self-motivation and internal cues in the absence of demon-
strable cognitive failure or motor weakness. Serotonin and
dopamine have been identified as critical neurotransmitters
in fatigue [26]. An animal study showed that levels of extra-
cellular dopamine and 5-HT neurotransmitters increased
significantly during exhausting exercise [27]. A reduced
level of dopamine has also been reported in fatigued rats
[28]. The reuptake of dopamine, but not the regulation of
serotonin levels, has been reported to restore performance
to some extent and in particular heat-mediated central
fatigue [28, 29]. Pharmacological evidence further supports
the importance of dopamine in fatigue [28]. In addition to
dopamine deficiency, several lines of evidence suggest that
the serotonergic system is also involved in the pathophys-
iology of PD [30, 31]. The failure of activation and central
fatigue in PD patients is likely due to aberrant dopamine and
serotonin systems. The potential mechanism may be related
to dopamine transporter binding in the posterior putamen,
the functional organization of basal ganglia, and connections
of the basal ganglia to cortical motor and premotor areas
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[6]. Basal ganglia are involved in the limbic modification
of cortical motor output via the dopaminergic system and
the serotonin pathway [32]. Such limbic modification could
affect motivation, thereby influencing the ability to sustain
voluntary activation after exercise. However, we failed to
find a correlation between LED or UPDRS III and fatigue
measures. This is perhaps not surprising, because the exper-
iments were performed when the patients were still taking
medications, and medications are likely to help partially
compensate for fatigue. Further studies including patients not
taking medications are warranted to evaluate the correlation
between daily levodopa supplements and serotonin-related
factors such as depression and fatigue measures.
Other mechanisms also contribute to central fatigue.
For example, central fatigue may result from insufficient
drive from supraspinal sites [13, 20] because of a lack of
subject motivation [32]. Recent studies have shown that
during exhaustive exercise, group III/IV muscle afferents
inhibit the motor cortex and promote central fatigue [33,
34]. During exercise, inadequate oxygen delivery to the
brain may contribute to the development of fatigue [28, 35].
Future studies should focus on whether PD patients are more
sensitive to group III/V inhibition and more vulnerable to
inadequate brain oxygen delivery.
We also found a reduced walking speed in the PD
patients, with an average of 93.99 ± 34.6m/s in the PD
group compared to 122.17 ± 34.27m/s in the HC group,
consistent with the study by Yang et al. [33]. Furthermore,
we found that this reduction in walking speed could be
partially explained by the peripheral component of knee
extensor force. Although the correlation was not enough
to infer their causal relationship, this finding is compatible
with a previous study which demonstrated thatmuscle power
was a significant determinant of walking speed in patients
with PD even after adjusting for UPDRS motor score [34].
Therefore, improvements in peripheral muscular strength
may help to improve the walking ability of PD patients.
However, it should be noted that several other factors such
as postural abnormalities, shorter stride, smaller forward
moment velocity, and abnormal trunk muscle strength may
also slow the walking speed in patients with PD [33].
4.1. Limitations. Tremors that may potentiate resting twitch
force may have been a confounding factor in this study.
However, we excluded subjects with obvious tremors and
those with tremors during recording to avoid this issue.
Moreover, only potentiated twitches recorded during muscle
activation were analyzed. Thus, the influence of tremors was
minimized by the experimental design. Another potential
limitation is that we did not balance the gender distribution
in the two groups.The reported influence of gender on fatigue
has been inconsistent, and a gender difference has been
reported in muscles of the upper extremities [35], but not of
the lower extremities [35, 36]. In the present study, muscles
in the lower extremities, that is, the quadriceps muscles, were
evaluated and no difference in the GFI of knee extensor
was found between groups. Hence, the difference in gender
distribution is unlikely to have influenced the results.
5. Conclusion
In this study, we found that PD patients suffered from
weakness of central origin in the prefatigue state.The patients
reported more subjective fatigue and presented with more
exercise-induced central fatigue than the HCs. In addition,
peripheral strength was found to be an important factor with
regard to the walking ability of the patients with PD. These
results provide an insight into the mechanism of weakness
and gait problems and may help with the development of
rehabilitation programs for patients with PD in improving
activation level, overcoming central fatigue and subjective
fatigue, which will in turn be helpful to overcome PD-related
weakness and fatigue. Peripheral muscle strength should be
enhanced to improve walking speed.
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